This makes the identified alterations in the abundance of specific isoforms of integrin, cadherin and caveolin in muscular dystrophy an interesting finding with potential for the establishment of a comprehensive biomarker signature of dystrophinopathy. The gene discussed is CDH17; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.